SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation ...

It began quietly—missing drugs deliveries, empty shelves—but today, Uganda’s healthcare system is facing a full-blown crisis ...

More than 20,000 jobs were eliminated, billions of dollars in scientific research has been threatened or paused, and a budget draft proposes a major restructuring of Health and Human Services.

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...

Dr. Marty Makary has been outspoken about vaccine mandates and other public health measures, so how does the Food and Drug ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.